Muscle-specific carbonic anhydrase III is a more sensitive marker of muscle damage than creatine kinase in neuromuscular disorders.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Archives of Neurology

• Publication date

  1988-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.1988.00520350092022PMID 3142447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and localization of human carbonic anhydrase

  2004cited by this paper
• Carbonic anhydrase-III immunohistochemical localization in human skeletal muscle

  2004cited by this paper
• Immunoelectron microscopic localization of carbonic anhydrase III in rat skeletal muscle

  2004cited by this paper
• Carbonic anhydrase III: a new histochemical marker for myoepithelial cells.

  1987cited by this paper
• Serum carbonic anhydrase III in myotonic dystrophy

  1986cited by this paper
• Nucleotide sequence, tissue-specific expression, and chromosome location of human carbonic anhydrase III: the human CAIII gene is located on the same chromosome as the closely linked CAI and CAII genes.

  1986cited by this paper
• Liberation of muscle carbonic anhydrase into serum during extensive exercise.

  1986cited by this paper
• Serum carbonic anhydrase III in progressive muscular dystrophy.

  1985cited by this paper
• Serum carbonic anhydrase III in neuromuscular disorders and in healthy persons after a long-distance run.

  1985cited by this paper
• Distribution of immunoreactive carbonic anhydrase III in various human tissues determined by a sensitive enzyme immunoassay method.

  1984cited by this paper
• Origins and Molecular Evolution of the Carbonic Anhydrase Isozymes a

  1984cited by this paper
• Fetal Plasma Carbonic Anhydrase III and Creatine Kinase in Duchenne Dystrophy

  1984cited by this paper
• Distribution of immunoreactive carbonic anhydrase III in various human tissues determined by a sensitive enzyme immunoassay method

  1984cited by this paper
• Carbonic anhydrase III in neuromuscular disorders.

  1983cited by this paper
• Carbonic anhydrase III in Duchenne muscular dystrophy.

  1983cited by this paper
• Susceptibility of mouse skeletal muscles to exercise injuries

  1983cited by this paper
• Immunoassay of human muscle enolase subunit in serum: a novel marker antigen for muscle diseases

  1983cited by this paper
• Immunoassay of human muscle enolase subunit in serum: a novel marker antigen for muscle diseases.

  1983cited by this paper
• Carbonic anhydrase activity in skeletal muscle fiber types, axons, spindles, and capillaries of rat soleus and extensor digitorum longus muscles.

  1982cited by this paper
• Enzyme Diagnosis in Diseases of the Heart, Liver and Pancreas

  1982cited by this paper
• Carbonic anhydrase in the type I skeletal muscle fibers of the rat. An immunohistochemical study.

  1982cited by this paper
• Clinical biochemistry of muscular dystrophy.

  1980cited by this paper
• Distribution of CAIII in fetal and adult human tissue

  1980cited by this paper
• Serum-carbonic-anhydrase-III in Duchenne dystrophy.

  1980cited by this paper
• Some Statistical Methods Useful in Circulation Research

  1980cited by this paper

• Carbonic Anhydrase 3 Overexpression Modulates Signalling Pathways Associated with Cellular Stress Resilience and Proteostasis

  2025cites this paper
• Serum protein biomarker signature of Duchenne muscular dystrophy

  2025cites this paper
• 5-aza-2-deoxycytidine improves skeletal muscle function in a mouse model for recessive RYR1-related congenital myopathy.

  2025cites this paper
• Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology

  2023cites this paper
• Biomarkers in Duchenne Muscular Dystrophy

  2022cites this paper
• Tissue-engineered human myobundle system as a platform for evaluation of skeletal muscle injury biomarkers.

  2020cites this paper
• Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies

  2014cites this paper
• Mass Spectrometry-Based Identification of Muscle-Associated and Muscle-Derived Proteomic Biomarkers of Dystrophinopathies

  2014cites this paper
• Serum Muscle Enzymes in Neuromuscular Disease

  2014cites this paper
• Proteomic identification of biomarkers of skeletal muscle disorders.

  2013cites this paper
• Carbonic anhydrase III: A neglected isozyme is stepping into the limelight

  2013cites this paper
• Mass spectrometry-based proteomic analysis of middle-aged vs. aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle

  2012cites this paper
• Functional Analysis of Expressed Sequence Tags from Hanwoo (Korean Cattle) cDNA Libraries

  2009cites this paper
• Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.

  2002cites this paper
• Production and characterization of monoclonal antibodies to human carbonic anhydrase III.

  1998cites this paper
• Biochemical markers of the acute coronary syndromes.

  1998cites this paper
• Myosin polymorphism and differential expression in adult human skeletal muscle.

  1993cites this paper
• Comparison of muscle-derived serum carbonic anhydrase III and myoglobin in dermatological patients: effects of isotretinoin treatment.

  1992cites this paper
• Serum from patients with amyotrophic lateral sclerosis induces the expression of B-50/GAP-43 and neurofilament in cultured rat fetal spinal neurons.

  1991cites this paper
• The Carbonic Anhydrases

  1991cites this paper
• Myoglobin is a sensitive marker of increased muscle membrane vulnerability

  1990cites this paper
• Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction.

  1990cites this paper